- The significance of serial histopathology in a residual mass for outcome of intermediate risk stage 3 neuroblastomaAraz Marachelian
Department of Pediatrics, Children s Hospital Los Angeles, USC Keck School of Medicine, Los Angeles, California, USA
Pediatr Blood Cancer 58:675-81. 2012..To describe the serial histopathology of intermediate risk stage 3 neuroblastoma after chemotherapy, and correlate with residual mass at therapy completion and outcome...
- Myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for childhood central nervous system tumorsA Marachelian
Childrens Center for Cancer and Blood Diseases, Childrens Hospital Los Angeles, CA 90027, USA
Bone Marrow Transplant 41:167-72. 2008..Here, we review results of myeloablative chemotherapy with hematopoietic progenitor cell rescue in brain tumors of different histologies...